Hi Guest
X   

Real-Time Quote

Enter Company or MF
   

Bafna Pharmaceuticals Ltd. - Research Center

532989  BAFNAPHAR  Group (T) BSE data View Tips   Add to :  Portfolio  |  Watchlist  |  Game

Results
Half yearly

Statement

More
(Rs crore)

Half yearly results in brief

 Sep ' 09Mar ' 09Sep ' 08
Sales 30.58 32.25 13.74
Operating profit 4.61 3.49 1.65
Interest 1.70 1.39 0.67
Gross profit 3.35 2.97 1.55
EPS (Rs) 1.37 0.46 0.22

Annual results in details

 Sep ' 09Mar ' 09Sep ' 08
Other income 0.43 0.88 0.57
Stock adjustment -4.76 1.00 1.00
Raw material 28.54 18.38 9.61
Power and fuel---
Employee expenses 1.24 0.91 0.61
Excise---
Admin and selling expenses---
Research and development expenses---
Expenses capitalised---
Other expenses 0.95 8.46 0.88
Provisions made---
Depreciation 0.87 0.53 0.84
Taxation- 1.41-
Net profit / loss 2.20 0.73 0.36
Extra ordinary item -0.28 -0.31 -0.35
Prior year adjustments---
Equity capital 15.98 15.98 15.98
Equity dividend rate---
Agg.of non-prom. shares (Lacs) 76.41 80.62 88.53
Agg.of non promotoholding (%) 47.81 50.45 55.39
OPM (%) 15.08 10.81 11.98
GPM (%) 10.79 8.97 10.84
NPM (%) 7.08 2.20 2.50